DOI: 10.1128/CVI.00591-14
Article Information
PubMed
Published By
History
- Received September 5, 2014
- Returned for modification September 24, 2014
- Accepted December 23, 2014
- Published online March 26, 2015.
Copyright & Usage
Copyright © 2015, American Society for Microbiology. All Rights Reserved. The authors have paid a fee to allow immediate free access to this article.
Editors and / or Reviewers
- S. A. Plotkin, Editor
Article Versions
- Accepted Manuscript version (February 04, 2015).
- You are viewing the most recent version of this article.
Author Information
- Dan Aptera,
- Cosette M. Wheelerb,
- Jorma Paavonenc,
- Xavier Castellsaguéd,
- Suzanne M. Garlande,
- S. Rachel Skinnerf,
- Paulo Naudg,
- Jorge Salmerónh,
- Song-Nan Chowi,
- Henry C. Kitchenerj,
- Julio C. Teixeirak,
- Unnop Jaisamrarnl,
- Genara Limsonm,
- Anne Szarewskin†,
- Barbara Romanowskio,
- Fred Y. Aokip,
- Tino F. Schwarzq,
- Willy A. J. Popper,
- F. Xavier Boschs,
- Adrian Mindelt,
- Philippe de Sutteru,
- Karin Hardtv,
- Toufik Zahafv,
- Dominique Descampsv,
- Frank Struyfv,
- Matti Lehtinenw and
- Gary Dubinx
- for the HPV PATRICIA Study Group
- aFamily Federation of Finland, Sexual Health Clinic, Helsinki, Finland
- bDepartments of Pathology and Obstetrics and Gynecology, University of New Mexico Health Sciences Center, Albuquerque, New Mexico, USA
- cDepartment of Obstetrics and Gynaecology, University of Helsinki, Helsinki, Finland
- dCancer Epidemiology Research Program, Institut Català d'Oncologia (ICO), IDIBELL, Biomedical Research Centre Network for Epidemiology and Public Health (CIBER-ESP), L'Hospitalet de Llobregat, Catalonia, Spain
- eMicrobiology and Infectious Diseases Department, Royal Women's Hospital and Department of Obstetrics and Gynaecology, University of Melbourne, Murdoch Childrens Research Institute, Melbourne, Victoria, Australia
- fVaccine Trials Group, Telethon Institute for Child Health Research, Perth, Western Australia, and Sydney University Discipline of Paediatrics and Child Health, Children's Hospital at Westmead, Sydney, New South Wales, Australia
- gUniversity Federal of Rio Grande do Sul, Hospital de Clínica de Porto Alegre, Porto Alegre, Brazil
- hUnidad de Investigación Epidemiológica y en Servicios de Salud, Instituto Mexicano del Seguro Social, Morelos, Mexico
- iDepartment of Obstetrics and Gynecology, College of Medicine and the Hospital, National Taiwan University, Taipei, Taiwan
- jManchester Academic Health Science Centre, Central Manchester University Hospitals NHS Foundation Trust, St Mary's Hospital, Manchester, United Kingdom
- kUniversity of Campinas, Campinas, Brazil
- lChulalongkorn University, Department of Obstetrics and Gynaecology, Faculty of Medicine, Bangkok, Thailand
- mUniversity of the Philippines, College of Medicine, Philippine General Hospital, Makati Medical Centre, Makati City, Philippines
- nCentre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, United Kingdom
- oUniversity of Alberta, Edmonton, Alberta, Canada
- pUniversity of Manitoba, Winnipeg, Manitoba, Canada
- qCentral Laboratory and Vaccination Centre, Stiftung Juliusspital, Academic Teaching Hospital of the University of Wuerzburg, Wuerzburg, Germany
- rDepartment of Gynaecology, University Hospital KU Leuven Gasthuisberg, Leuven, Belgium
- sCancer Epidemiology Research Program, Institut Català d'Oncologia (ICO), IDIBELL, Network on Cooperative Cancer Research (RTICC), L'Hospitalet de Llobregat, Catalonia, Spain
- tCentre for AIDS Programme of Research in South Africa, Durban, South Africa
- uAfdelingshoofd Gynaecologie-Oncologie, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels, Belgium
- vGSK Vaccines, Wavre, Belgium
- wUniversity of Tampere, School of Public Health, Tampere, Finland
- xGSK Vaccines, King of Prussia, Pennsylvania, USA
- Address correspondence to Dan Apter, dan.apter{at}vaestoliitto.fi.
↵† Deceased.
Citation Apter D, Wheeler CM, Paavonen J, Castellsagué X, Garland SM, Skinner SR, Naud P, Salmerón J, Chow S-N, Kitchener HC, Teixeira JC, Jaisamrarn U, Limson G, Szarewski A, Romanowski B, Aoki FY, Schwarz TF, Poppe WAJ, Bosch FX, Mindel A, de Sutter P, Hardt K, Zahaf T, Descamps D, Struyf F, Lehtinen M, Dubin G, HPV PATRICIA Study Group. 2015. Efficacy of human papillomavirus 16 and 18 (HPV-16/18) AS04-adjuvanted vaccine against cervical infection and precancer in young women: final event-driven analysis of the randomized, double-blind PATRICIA trial. Clin Vaccine Immunol 22:361–373. doi:10.1128/CVI.00591-14.
Article usage
Efficacy of Human Papillomavirus 16 and 18 (HPV-16/18) AS04-Adjuvanted Vaccine against Cervical Infection and Precancer in Young Women: Final Event-Driven Analysis of the Randomized, Double-Blind PATRICIA Trial
